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Expression of the Thy- 1  (theta) antigen is one of the most distinguishing character- 
istics  of T  cells in mice (1, 2) and rats (3). This differentiation antigen is expressed in 
large quantities on cells from brain and thymus and to a  lesser extent on fibroblast- 
derived cell lines of both mouse and rat  (4).  The Thy-1 molecule has been purified 
from murine T  lymphoblastoid cells (5) and murine brain (6, 7), as well as rat thymus 
(8)  and  brain  (9).  It is a  glycoprotein of ~25,000-28,000  daltons as determined by 
sodium  dodecyl sulfate-polyacrylamide gel  electrophoresis  (SDS-PAGE)J  We have 
recently used an antiserum prepared against monkey thymocytes to identify a 25,000- 
dalton surface membrane antigen expressed on normal  human  T  lymphocytes and 
human T  lymphoblastoid cells (10).  These data suggested that a human counterpart 
of rodent Thy- 1 might exist. 
In this study, we describe the isolation and preliminary characterization of a 25,000- 
mol wt membrane protein (p25) from the human T  lymphoblastoid cell line MOLT- 
3.  The methodologic approach was  essentially the same as previously used  for the 
large-scale purification of mouse Thy-1 antigen  (5).  Extensive antigenic similarities 
between purified mouse Thy-l.1 and the p25 protein were demonstrated with both 
goat anti-Thy-1 and rabbit anti-p25 sera. The results indicate that the p25 antigen is 
the homologue of Thy- 1. 
Materials and Methods 
The human T-cell antigen was purified from a starting population of 4 X  l0 w MOLT-3 cells 
grown  in  spinner suspension cultures  in  RPMI-1640  (Grand  Island  Biological  Co.,  Grand 
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Island, N. Y.) plus 10% heat-inactivated horse serum. The cells were collected and disrupted as 
previously described (11). Nuclei and cell debris were removed by centrifugation at 400 g for 15 
min.  The  supernate  was  centrifuged  for  20  min  at  4,000  g.  The  resulting  supernate  was 
centrifuged at 20,000 g for 1 h to harvest a microsomal pellet. This was resuspended in 10 mM 
Tris-H(21,  pH 8.2, and mixed with 10 vol of acetone at -70°(2. After centrifugation at 3,000 g 
for 15 min, the pellet was solubilized in 2.5% deoxycholate (DO(3) as previously described (5). 
Nonsolubilized material was removed by centrifugation at  100,000 g for 1 h. 
The  solubilized antigen  was  then  isolated  by  affinity chromatography  followed  by  gel 
filtration. Lens culinaris  lectin coupled to Sepharose 4B  (Pharmacia Fine Chemicals, Div. of 
Pharmacia, Inc., Piscataway, N. J.) was prepared by the method of Allan et al. (12) and used 
to  prepare a  column equilibrated with 0.5%  DOC,  10  mM  Tris-HCl  (pH  8.2)  buffer.  The 
100,000 g supernate of the DOC-solubilized pellet was passed through this column, the unbound 
material was removed by washing with buffer, and the glycoproteins were then eluted with 3% 
alpha-methyl-D-glucoside in the same buffer. The eluted fraction was concentrated by adding 
3 vol of absolute ethanol and incubating at -20°C for 48 h. The suspension was centrifuged at 
300 g for 15 min, the ethanol decanted, and the pellet resuspended in a small volume of buffer. 
Gel filtration of the resuspended pellet was carried out on a  2.5  ×  100-cm  Ultrogel AcA-34 
(LKB Instruments, Inc., Rockville, Md.) column in 0.5% DO(2,  10 mM Tris-HCl, pH 8.2. 
An antiserum was raised in rabbits against the 25,000-dalton fraction isolated from the AcA- 
34 column. The molecular weight of the protein peak was determined by SDS-PAGE. The first 
injection of antigen was  administered intramuscularly in  complete Freund's adjuvant.  The 
second and third injections were given  14 and 28 d  later with incomplete Freund's adjuvant. 
The  antiserum  (anti-p25) was  heat  inactivated and  used  in  these experiments without  any 
adsorptions.  A  goat  antiserum  raised  against  purified  Thy-1  (goat  anti-purified  Thy-l.1 
molecule  [anti-p  Thy-1])  isolated  from  a  mouse  AKR-derived T  lymphoblastoid cell  line 
(BW5147) was prepared as previously described (5). 
Surface membrane determinants reactive with these two antisera were examined by solubi. 
lizing radiolabeled lymphocyte membrane  antigens in 0.5%  DOC  and  then  coprecipitating 
them with antiserum and Staphylococcus aureus (2owan strain I (Staph protein A) as previously 
described  (10).  They  were  then  analyzed  by  SDS-PAGE  on  a  5-12%  gradient  gel  in  a 
discontinuous buffer system using the method of Laemmli (13). The gels were sliced into 1-mm 
slices and counted on a  Beckman  Bio-Gamma gamma counter  (Beckman Instruments, Inc., 
Fullerton, Calif.). Relative mobilities (Rf) were expressed as the ratio of the length of migration 
of the sample and a  bromophenol blue dye marker.  Known  proteins used for estimation of 
molecular weight were bovine serum albumin (BSA) (68,000),  ovalbumin (45,000),  chymotryp- 
sinogen  A  (25,000),  and  myogtobin  (17,000).  A  standard  curve  was  used  to  estimate  the 
molecular weights of the antigens. 
Results 
Solubilized membranes of human lymphocytes were treated with unabsorbed anti- 
p25  serum raised against purified human  T-cell antigen. Anti-p25 precipitated only 
one protein of 25,000 daltons from E-rosette-positive T  cells from human blood (Fig. 
1 A).  No  labeled material  was  precipitated  from  solubilized membranes  of a  B-cell 
leukemia  (pre-B-cell type).  Cross-reactivity between  the  human  and  mouse  T-cell 
antigens was demonstrated in experiments in which anti-p25 was used to precipitate 
purified radiolabeled mouse Thy- 1.1  antigen (Fig.  1 A). Neither the prebleed normal 
rabbit serum  and  Staph  protein A  nor  Staph  protein A  alone precipitated Thy-l.1 
antigen.  Immunodepletion experiments were  then  performed  to determine  whether 
the anti-p25 serum and the anti-p Thy-1  serum were recognizing the same antigenic 
component. When an excess of anti-p25 serum plus Staph protein A  was first used to 
coprecipitate  purified  Thy-l.1,  no  additional  material  was  precipitated  from  the 
depleted supernate  by  a  second  precipitation step  with  anti-p  Thy-l.1  plus  Staph 
protein  A  (Fig.  1B).  Conversely, rabbit  anti-p25  did  not  precipitate Thy-1  protein 402  HUMAN  THY-I  HOMOLOGUE 
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FIG.  1.  Migration profile on SDS-PAGE of detergent-solubilized  lymphocyte antigens coprecipi- 
tared with a rabbit antiserum raised against a purified human T antigen (anti-p25). (A) Anti-p25 
recognizes a 25,000-dahon antigen from human blood T cells (E-rosette receptor positive) and cross- 
reacts with purified mouse Thy-l.l antigen with the same molecular weight. This reagent was 
unreactive with membrane proteins from leukemic B cells. (B) lmmunodepletion experiments were 
performed where rabbit anti-p25 was coprecipitated with purified mouse Thy-1.1. After cenlrifu- 
gation, the supernate lacked any antigens that  could be coprecipitated with an anti-p Thy-l.1 
serum. 
from preparations previously reacted with anti-p Thy-1 (data not shown, but identical 
to Fig.  1 B). 
The cross-species reactivity of anti-p25 for mouse T  lymphocytes was  also deter- 
mined with  a  SlCr release cytotoxicity assay  (5).  Anti-p25 serum was  cytotoxic for 
virtually all AKR/Jax  (The Jackson  Laboratory,  Bar  Harbor,  Maine)  mouse thy- 
mocytes in the presence of guinea pig complement, but was unreactive with mouse 
bone marrow cells (Fig. 2). The same results were obtained with goat anti-p Thy-1.1. 
The 50% cytotoxicity titer of anti-p25 was  1:8 for human T  lymphoblastoid target 
cells  (MOLT-3)  and  1:64  for cuhured mouse T  cells  (BW5147)  in the  presence of 
rabbit serum as a complement source. No lysis of MOLT-3 cells occurred with guinea 
pig serum as a  complement source. Reactivity of anti-p25 serum with MOLT-3 ceils 
was also demonstrated by a  direct immunofluorescence assay (10). 
Quantitative immunoadsorption studies  were  performed  using  purified  murine 
Thy-l.2, AKR/Jax  thymocytes, AKR/Jax  brain membranes, and human MOLT-3 goat anti-pThy-1.1 
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Fig.  2.  Cytotoxicity of rabbit anti-p25 and goat anti-p Thy- i. 1 sera were reacted with 5:Cr-Iabeled 
AKR/Jax lymphocytes from thymus (0) or bone marrow (X). Percent specific  release was calculated 
with the formula: 
Counts released by antiserum 
% Release =  -  counts released in complement control X 100. 
Maximum counts released by acid. lysis 
-  counts released in complement control 
This experiment is representative of three individual  studies that show that anti-p25 serum cross- 
reacts with mouse thymocytes but is unreactive with marrow lymphoid cells. 
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membranes  (not  detergent  solubilized)  obtained  by differential centrifugation  (5). 
Before adsorptions, each antiserum  was diluted to a  titer that  was  not  in antibody 
excess but was still cytotoxic for >50% ofAKR/Jax thymocytes as previously described 
(5).  50  #1  of antiserum  at  the  appropriate  dilution  was  incubated  with  an  equal 
volume of serial dilutions of the adsorbing material for 2 h  at 4°C. The membrane 
protein concentration of each adsorbing material was determined by the method of 
Lowry et al. (14) with BSA as a standard. The results confirmed again that there was 
cross-reactivity of the human and murine T  antigens, because membranes or purified 
antigens from either species reciprocally removed the cytoxic activity of both antisera 
for AKR thymocytes (Fig. 3).  There were quantitative differences in the adsorbing 
efficiency of the various preparations. Thus, the quantity of MOLT-3 cell membranes 
required for complete antibody adsorption was 10-fold greater than that of AKR/Jax 
brain  or thymocyte membrane and  100-fold greater than  the  quantity  of purified 
Thy-l.1 antigen (Fig. 3). 
Discussion 
We  have  previously  demonstrated  cross-reacting  T  lymphocyte  differentiation 
antigens among mammalian species (15). With few exceptions, no cross-reactivity of 
lymphocyte antigens was demonstrated between any phylogenetic order, On the other 
hand, serological cross-reactivity between humans and rodents has been demonstrated 
for histocompatibility antigens and for immunoglobulin products of B cells (16-18). 
A  homology between a  human T-cell antigen and murine Thy-1  is suggested by 
the  following observations:  (a)  the  antigens  have  a  similar  mol  wt  of ~25,000  as 40 
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FIG. 3.  Quantitative adsorption of rabbit anti-p25 (1/15 dilution) and goat anti-p Thy-l.1  (1/35 
dilution) with purified AKR/Jax thymocyte membrane (m), MOLT-3 cell membrane (O), AKR/ 
Jax brain membrane (×), or purified Thy-1 (A) and tested on AKR/Jax thymocytes as target cells. 
Activity of both antisera was removed by purified T antigens from the isologous  and heterologous 
species. 
determined by SDS-PAGE; (b) they are glycoproteins that bind to L. culinaris;  (c)  the 
p25  antigen  from human MOLT-3 cells elicited  an antiserum  that cross-reacts with 
mouse Thy-1  both  by radioimmunoprecipitation  and  by complement-mediated  cy- 
totoxicity;  and  (d)  anti-p25  and  anti-p  Thy-1  reacted  with  the  same  antigen  as 
demonstrated by adsorption and immunodepletion experiments. The cytotoxicity and 
the  quantitative  adsorption  experiments  indicate  a  relatively  low  density  of Thy-1 
homologue  on  cultured  human  MOLT-3  cells  compared  with  mouse  T  cells  and ADES, ZWERNER, ACTON, AND BALCH  405 
brain.  This data  thus supports previous suggestions  (19,  20)  that  there  is a  human 
homologue of rodent Thy-1 analogous to the classical and physicochemical description 
of the  purified  Thy-1  molecule.  Whether the  molecular structure  of the  human  T 
antigen is identical to the already defined rat and mouse Thy-1 molecule remains to 
be determined. 
Human T-cell  membranes are known to contain a  multitude  of antigenic deter- 
minants  with  different  molecular weights  (21).  The  ability  to  purify  and  then  to 
immunize with immunochemically defined human T-cell antigens has the advantage 
of producing monospecific xeno-antisera requiring little  if any adsorptions or mono- 
clonal antibodies produced by antigen-directed hybridomas. Owen and Fanger (22) 
have previously prepared anti-human T-cell sera by immunizing rabbits with purified 
antigens taken from slices of a polyacrylamide gel. The yield of antigen with such an 
approach  is  relatively  low.  On  the  other  hand,  human  lymphocyte  membrane 
glycoproteins can be  isolated  in  microgram to milligram  quantities  as described  in 
this report when employing a  system that includes large-scale tissue culture, affinity 
chromatography, and  gel  filtration  chromatography. This  yield and  purity should 
facilitate future studies of human T  antigens with respect to their molecular nature 
and  biological  properties  of T  lymphocytes displaying  them  on  their  membrane 
surface. 
Summary 
A glycoprotein of 25,000 daltons was isolated from a human T  lymphoblastoid cell 
line  (MOLT-3).  A  monovalent  antiserum  raised  against  this  antigen  precipitated 
mouse Thy-1.1 antigen as well as a  25,000-dalton antigen from human blood T  cells. 
The unabsorbed  serum  was also cytotoxic for both  mouse and  human  T  cells.  By 
multiple criteria, this human T  antigen appears to be homologous with mouse Thy- 1. 
The authors  wish to gratefully acknowledge Randy Phillips, Mike Cox, and Judy Williams for 
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